MET409 being evaluated for the treatment of NASH by Metacrine Investigative Site lowers liver content of fat, but still induces differentiated pruritus and LDL-C profile
Kietzman D, Bock KW, Krahmer B, Kettler D, Bircher J: Paracetamol test: modification by renal function, urine flow, and pH
Regulated as a cosmetic, meaning manufacturers cannot claim it cures or prevents disease
Add a pinch of salt to boost sodium
novonordisk.com/content/nncorp Top-Line Summary: REDEFINE 4 (CagriSema vs Tirzepatide) - - - CagriSema: 23.0% weight loss (efficacy estimand) Tirzepatide: 25.5% weight loss Treatment-regimen estimand: CagriSema 20.2% Tirzepatide 23.6% Primary endpoint: Not met (non-inferiority) Safety: Mostly GI AEs, consistent with class Perspective: A therapy producing ~23% weight loss is framed as missing. Thats how far obesity pharmacotherapy has progressed
How to Use Retatrutide 10mg in Research Reconstitution: Add 1.0 mL to 1.5 mL of bacteriostatic water or sterile water (based on experimental design) to the vial
